Literature DB >> 29760136

Aztreonam-Avibactam Combination Restores Susceptibility of Aztreonam in Dual-Carbapenemase-Producing Enterobacteriaceae.

Ka Lip Chew1, Michelle K L Tay2, Bernadette Cheng2, Raymond T P Lin2,3, Sophie Octavia3, Jeanette W P Teo2.   

Abstract

Entities:  

Keywords:  aztreonam-avibactam; carbapenem-resistant Enterobacteriaceae; carbapenemase; meropenem-vaborbactam; multidrug-resistant bacteria

Mesh：

Substances：

Year:  2018        PMID： 29760136      PMCID： PMC6105852          DOI： 10.1128/AAC.00414-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  14 in total

1.  In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli.

Authors:  Shawn Vasoo; Scott A Cunningham; Nicolynn C Cole; Peggy C Kohner; Sanjay R Menon; Kevin M Krause; Kelly A Harris; Partha P De; Tse Hsien Koh; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015.

Authors:  James A Karlowsky; Krystyna M Kazmierczak; Boudewijn L M de Jonge; Meredith A Hackel; Daniel F Sahm; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

Review 3.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

4.  Emergence of Klebsiella pneumoniae co-producing NDM-type and OXA-181 carbapenemases.

Authors:  M N D Balm; M-V La; P Krishnan; R Jureen; R T P Lin; J W P Teo
Journal:  Clin Microbiol Infect       Date:  2013-05-13       Impact factor: 8.067

5.  In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013.

Authors:  Douglas J Biedenbach; Krystyna Kazmierczak; Samuel K Bouchillon; Daniel F Sahm; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2015-05-11       Impact factor: 5.191

6.  Molecular characterization of NDM-1 producing Enterobacteriaceae isolates in Singapore hospitals.

Authors:  Jeanette Teo; Grace Ngan; Michelle Balm; Roland Jureen; Prabha Krishnan; Raymond Lin
Journal:  Western Pac Surveill Response J       Date:  2012-03-29

7.  Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae.

Authors:  Mariana Castanheira; Paul R Rhomberg; Robert K Flamm; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

8.  Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.

Authors:  Kalisvar Marimuthu; Indumathi Venkatachalam; Wei Xin Khong; Tse Hsien Koh; Benjamin Pei Zhi Cherng; My Van La; Partha Pratim De; Prabha Unny Krishnan; Thean Yen Tan; Raymond Fong Kok Choon; Surinder Kaur Pada; Choong Weng Lam; Say Tat Ooi; Rama Narayana Deepak; Nares Smitasin; Eng Lee Tan; Jia Jun Lee; Asok Kurup; Barnaby Young; Nancy Tee Wen Sim; Koh Cheng Thoon; Dale Fisher; Moi Lin Ling; Brenda Ang Sze Peng; Yik-Ying Teo; Li Yang Hsu; Raymond Tzer Pin Lin; Rick Twee-Hee Ong; Jeanette Teo; Oon Tek Ng
Journal:  Clin Infect Dis       Date:  2017-05-15       Impact factor: 9.079

9.  Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.

Authors:  Olga Lomovskaya; Dongxu Sun; Debora Rubio-Aparicio; Kirk Nelson; Ruslan Tsivkovski; David C Griffith; Michael N Dudley
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

Review 10.  Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health.

Authors:  Asad U Khan; Lubna Maryam; Raffaele Zarrilli
Journal:  BMC Microbiol       Date:  2017-04-27       Impact factor: 3.605
View more
  16 in total

Review 1.  Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles.

Authors:  Olivia Smibert; Michael J Satlin; Anoma Nellore; Anton Y Peleg
Journal:  Curr Infect Dis Rep       Date:  2019-06-10       Impact factor: 3.725

2.  Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria.

Authors:  Cécile Emeraud; Lelia Escaut; Athénaïs Boucly; Nicolas Fortineau; Rémy A Bonnin; Thierry Naas; Laurent Dortet
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

3.  In vitro selection of aztreonam/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniae.

Authors:  Siqiang Niu; Jie Wei; Chunhong Zou; Kalyan D Chavda; Jingnan Lv; Haifang Zhang; Hong Du; Yi-Wei Tang; Johann D D Pitout; Robert A Bonomo; Barry N Kreiswirth; Liang Chen
Journal:  J Antimicrob Chemother       Date:  2020-03-01       Impact factor: 5.790

4.  Genetic Features Leading to Reduced Susceptibility to Aztreonam-Avibactam among Metallo-β-Lactamase-Producing Escherichia coli Isolates.

Authors:  Mustafa Sadek; Mario Juhas; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

5.  Validation of Aztreonam-Avibactam Susceptibility Testing Using Digitally Dispensed Custom Panels.

Authors:  Eric Ransom; Amelia Bhatnagar; Jean B Patel; Maria-Jose Machado; Sandra Boyd; Natashia Reese; Joseph D Lutgring; David Lonsway; Karen Anderson; Allison C Brown; Christopher A Elkins; J Kamile Rasheed; Maria Karlsson
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

6.  Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam.

Authors:  Majed F Alghoribi; Moayad Alqurashi; Liliane Okdah; Bassam Alalwan; Yahya S AlHebaishi; Abdulmajeed Almalki; Maha A Alzayer; Abdulrahman A Alswaji; Michel Doumith; Mazin Barry
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

7.  Therapeutic Effect and Mechanisms of the Novel Monosulfactam 0073.

Authors:  Ying Sun; Xueyuan Liao; Zhigang Huang; Yaliu Xie; Yanbin Liu; Cuicui Ma; Boguang Jiang; Li Zhang; Yuhang Yan; Guobo Li; Xingjun Cheng; Qi Yin; Charles Z Ding; Liang Shen; Jian Li; Shuhui Chen; Yuquan Wei; Zhenling Wang; Xiawei Wei
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

8.  Detection and Characterization of Targeted Carbapenem-Resistant Health Care-Associated Threats: Findings from the Antibiotic Resistance Laboratory Network, 2017 to 2019.

Authors:  Sarah Sabour; Jennifer Y Huang; Amelia Bhatnagar; Sarah E Gilbert; Maria Karlsson; David Lonsway; Joseph D Lutgring; J Kamile Rasheed; Alison Laufer Halpin; Richard A Stanton; Stephanie Gumbis; Christopher A Elkins; Allison C Brown
Journal:  Antimicrob Agents Chemother       Date:  2021-09-27       Impact factor: 5.191

Review 9.  Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects.

Authors:  Shio-Shin Jean; Nan-Yao Lee; Hung-Jen Tang; Min-Chi Lu; Wen-Chien Ko; Po-Ren Hsueh
Journal:  Front Microbiol       Date:  2018-11-27       Impact factor: 5.640

10.  Detection of Pan drug resistance OXA-48 producing Providencia in an ICU patient for the first time in Nepal.

Authors:  Ranjit Sah; Shusila Khadka; Gentle Sunder Shrestha; Subhash Acharya; Diptesh Aryal; Pramesh Shrestha; Hari Prasad Kattel; Niranjan Prasad Shah; Bharat Mani Pokhrel; Yogendra Prasad Singh; Basista Rijal; Hakan Erdem
Journal:  Antimicrob Resist Infect Control       Date:  2019-10-15       Impact factor: 4.887
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.